Another group used the UPII promoter to drive an E1A-androgen receptor (E1A-AR) fusion protein expression, where intratumoral injection of Ad/PSCAE/UPII/E1A-AR significantly reduced bladder tumor growth in subcutaneous mouse models (Zhai et al., 2012). Here, UPK2 is linked to urinary bladder neoplasm.